Long-Lived Mammals Show Stronger Conservation at Cancer-Linked Genomic Sites
Researchers compared cancer-associated genomic regions across 58 mammalian species with varying lifespans. Long-lived species showed greater evolutionary conservation at these sites than at cancer-unrelated regions, while short-lived species did not. The study also found differences in epigenetic marks, including m6A enrichment near cancer-associated loci and tumor suppressor transcripts in long-lived mammals.
Researchers examined genomic regions tied to cancer in 58 mammals with different lifespans. In long-lived species, these regions appeared more evolutionarily conserved than regions unrelated to cancer; short-lived species did not show that pattern. The work also considered body size and mutation rates.
Long-lived mammals displayed distinct epigenetic features, including increased m6A near cancer-linked loci despite lower global m6A, and more m6A-modified tumor suppressor transcripts. Species such as naked mole rats, elephants, and certain bats are known for enhanced cancer resistance, making them key comparisons.
This research may inform future cancer-prevention strategies by highlighting protective mechanisms evolved in long-lived mammals. Patients, clinicians, and drug developers could eventually benefit if these insights translate into therapies, though any clinical application remains distant and uncertain. Comparative studies may also shape how scientists prioritize genomic targets, but they do not directly change care today.